Roubaix Capital LLC lowered its position in Neogen Corporation (NASDAQ:NEOG – Free Report) by 55.3% in the third quarter, HoldingsChannel reports. The fund owned 307,149 shares of the company’s stock after selling 379,963 shares during the quarter. Roubaix Capital LLC’s holdings in Neogen were worth $3,932,000 at the end of the most recent reporting period.
Several other hedge funds have also modified their holdings of the company. Bank of America Corp DE purchased a new position in shares of Neogen in the 2nd quarter valued at about $28,280,000. Bank of New York Mellon Corp acquired a new position in Neogen in the 2nd quarter worth about $11,404,000. The Manufacturers Life Insurance Company acquired a new position in Neogen in the 2nd quarter worth about $956,000. Sei Investments Co. boosted its position in Neogen by 69.1% during the first quarter. Sei Investments Co. now owns 230,403 shares of the company’s stock worth $2,141,000 after purchasing an additional 94,148 shares in the last quarter. Finally, American Capital Management Inc. purchased a new position in shares of Neogen during the 2nd quarter valued at approximately $1,200,000. 96.73% of the stock is owned by hedge funds and other institutional investors.
Neogen Trading Up 0.2%
NEOG stock opened at $10.90 on Wednesday. The company has a current ratio of 3.90, a quick ratio of 2.92 and a debt-to-equity ratio of 0.37. Neogen Corporation has a 12-month low of $5.37 and a 12-month high of $14.26. The stock has a market cap of $2.38 billion, a price-to-earnings ratio of -43.60, a PEG ratio of 3.89 and a beta of 1.86. The business’s 50-day moving average is $12.20 and its 200 day moving average is $10.53.
Neogen (NASDAQ:NEOG – Get Free Report) last posted its quarterly earnings data on Tuesday, October 6th. The company reported $0.08 EPS for the quarter, topping the consensus estimate of $0.05 by $0.03. Neogen had a positive return on equity of 3.29% and a negative net margin of 6.35%. The company had revenue of $222.80 million during the quarter, compared to analyst estimates of $208.18 million. During the same period in the previous year, the business earned $0.04 EPS. Neogen’s quarterly revenue was up 6.5% on a year-over-year basis. On average, sell-side analysts anticipate that Neogen Corporation will post 0.28 EPS for the current fiscal year.
Analyst Ratings Changes
A number of equities research analysts recently issued reports on NEOG shares. Wall Street Zen raised shares of Neogen from a “buy” rating to a “strong-buy” rating in a research note on Saturday. Weiss Ratings reissued a “sell (d-)” rating on shares of Neogen in a report on Wednesday, November 4th. Piper Sandler upgraded shares of Neogen from a “neutral” rating to an “overweight” rating and upped their price objective for the stock from $13.00 to $14.00 in a research report on Wednesday, August 26th. Finally, Guggenheim reaffirmed a “buy” rating and set a $14.00 price objective (up from $12.00) on shares of Neogen in a report on Wednesday, September 30th. Three investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Neogen presently has a consensus rating of “Hold” and a consensus target price of $12.67.
View Our Latest Stock Report on Neogen
About Neogen
Neogen Corporation develops and markets products and services focused on food and animal safety. Its offerings help food producers, processors, laboratories and livestock producers detect risks, support animal health and meet safety and quality requirements. Neogen’s food safety products include tests for foodborne pathogens, allergens, toxins and sanitation indicators, as well as related laboratory supplies and services. Its animal safety offerings include veterinary instruments, animal health products, biosecurity solutions and genetic testing services for livestock.
Featured Stories
- Five stocks we like better than Neogen
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Want to see what other hedge funds are holding NEOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Neogen Corporation (NASDAQ:NEOG – Free Report).
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.
